Aevitas Wealth Management, Inc. Bristol Myers Squibb CO Transaction History

Aevitas Wealth Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 26, 2019	SELL	$44.62 - $49.34 $9,057 - $10,016	-203 Closed	0 $0
Q1 2019 May 09, 2019	BUY	$45.12 - $53.8 $45 - $53	1 Added 0.5%	203 $9,000
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $4,778 - $6,196	-98 Reduced 32.67%	202 $10,000
Q3 2018 Nov 14, 2018	BUY	$55.19 - $62.25 $16,557 - $18,675	300 New	300 $19,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Aevitas Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Aevitas Wealth Management, Inc. with notifications on news.